Title |
Real-World Evidence Outcomes in the Use of Bevacizumab in Age-Related Macular Degeneration (ArMD): A Scoping Review Protocol |
Review Team |
Ainhoa Gomez-Lumbreras, Theodoros Giannouchos, Rupesh Panchal, Priyanka Ghule, Cate M. Lockhart, Diana Brixner |
Organizational Affiliation |
University of Utah |
Department or Division |
University of Utah College of Pharmacy; Biologics and Biosimilars Collective Intelligence Consortium |
DOI |
https://doi.org/10.26052/0d-b3vq-8d5m |
Citation |
Ainhoa Gomez-Lumbreras, Theodoros Giannouchos, Rupesh Panchal, Priyanka Ghule, Cate M. Lockhart, Diana Brixner. Real-world evidence outcomes in the use of bevacizumab in Age-Related Macular Degeneration (ArMD): a scoping review protocol. 2021. Protocol Registry of Evidence Reviews at the University of Utah. Available from DOI: https://doi.org/10.26052/0d-b3vq-8d5m |
Country |
USA |
Language |
eng |
Date |
2021 |
Date of Protocol |
April 23, 2021 |
Date Digital |
2022 |
Type of Review |
Scoping Review |
Type |
Text |
Format |
application/pdf |
Rights Management |
Copyright © 2022, University of Utah, All Rights Reserved |
Subject |
Macular Degeneration; Evidence-Based Pharmacy Practice; Evidence-Based Medicine; Endothelial Growth Factors; Angiogenesis Inhibitors; Bevacizumab; Ranibizumab; Treatment Outcome; Systematic Reviews as Topic; Review Literature as Topic; Registries; Databases, Bibliographic; Meta-Analysis; Data Curation; Guideline Adherence |
ARK |
ark:/87278/s6fpqdg3 |
Setname |
ehsl_esp |
ID |
1738259 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6fpqdg3 |